1. Home
  2. ZEUS vs GLUE Comparison

ZEUS vs GLUE Comparison

Compare ZEUS & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEUS
  • GLUE
  • Stock Information
  • Founded
  • ZEUS 1954
  • GLUE 2019
  • Country
  • ZEUS United States
  • GLUE United States
  • Employees
  • ZEUS N/A
  • GLUE N/A
  • Industry
  • ZEUS Metal Fabrications
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEUS Industrials
  • GLUE Health Care
  • Exchange
  • ZEUS Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • ZEUS 352.6M
  • GLUE 351.2M
  • IPO Year
  • ZEUS 1994
  • GLUE 2021
  • Fundamental
  • Price
  • ZEUS $31.03
  • GLUE $4.32
  • Analyst Decision
  • ZEUS Buy
  • GLUE Buy
  • Analyst Count
  • ZEUS 1
  • GLUE 2
  • Target Price
  • ZEUS $38.00
  • GLUE $13.50
  • AVG Volume (30 Days)
  • ZEUS 74.4K
  • GLUE 446.5K
  • Earning Date
  • ZEUS 07-31-2025
  • GLUE 08-07-2025
  • Dividend Yield
  • ZEUS 2.09%
  • GLUE N/A
  • EPS Growth
  • ZEUS N/A
  • GLUE N/A
  • EPS
  • ZEUS 1.23
  • GLUE 0.29
  • Revenue
  • ZEUS $1,878,204,000.00
  • GLUE $177,986,000.00
  • Revenue This Year
  • ZEUS $1.61
  • GLUE $49.02
  • Revenue Next Year
  • ZEUS $6.64
  • GLUE N/A
  • P/E Ratio
  • ZEUS $25.01
  • GLUE $14.39
  • Revenue Growth
  • ZEUS N/A
  • GLUE 14889.38
  • 52 Week Low
  • ZEUS $26.32
  • GLUE $3.50
  • 52 Week High
  • ZEUS $44.01
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • ZEUS 40.98
  • GLUE 32.45
  • Support Level
  • ZEUS $29.70
  • GLUE $4.16
  • Resistance Level
  • ZEUS $31.25
  • GLUE $4.98
  • Average True Range (ATR)
  • ZEUS 1.16
  • GLUE 0.33
  • MACD
  • ZEUS -0.31
  • GLUE -0.18
  • Stochastic Oscillator
  • ZEUS 19.27
  • GLUE 0.26

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: